Market closedNon-fractional

Olema Pharmaceuticals/OLMA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Olema Pharmaceuticals

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Ticker

OLMA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

San Francisco, United States

Employees

76
Website
olema.com

OLMA Metrics

BasicAdvanced
$596M
Market cap
-
P/E ratio
-$2.03
EPS
2.10
Beta
-
Dividend rate
$596M
2.1
9.613
9.52
0.487
0.487
-29.84%
-48.31%
2.52
2.52
-6.017
-26.16%
-4.46%

What the Analysts think about OLMA

Analyst Ratings

Majority rating from 9 analysts.
Buy

OLMA Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$31M
15.73%
Profit margin
0.00%
NaN%

OLMA Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 2.59%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.49
-$0.48
-$0.49
-$0.56
-
Expected
-$0.73
-$0.51
-$0.48
-$0.55
-$0.57
Surprise
-32.61%
-6.11%
1.89%
2.59%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Olema Pharmaceuticals stock?

Olema Pharmaceuticals (OLMA) has a market cap of $596M as of July 05, 2024.

What is the P/E ratio for Olema Pharmaceuticals stock?

The price to earnings (P/E) ratio for Olema Pharmaceuticals (OLMA) stock is 0 as of July 05, 2024.

Does Olema Pharmaceuticals stock pay dividends?

No, Olema Pharmaceuticals (OLMA) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Olema Pharmaceuticals dividend payment date?

Olema Pharmaceuticals (OLMA) stock does not pay dividends to its shareholders.

What is the beta indicator for Olema Pharmaceuticals?

Olema Pharmaceuticals (OLMA) has a beta rating of 2.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Olema Pharmaceuticals stock

Buy or sell Olema Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing